RNA Q1 2022 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-33.6% YoY

Gross Profit

-$26M-1442.5% margin

Operating Income

-$34M-1919.8% margin

Net Income

-$34M-1907.2% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-3.1%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$421M

Total Liabilities

$45M

Stockholders' Equity

$376M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-33.6%
Gross Profit	-$26M	-$18M	-44.1%
Operating Income	-$34M	-$24M	-44.4%
Net Income	-$34M	-$24M	-43.6%